Perspective highlights real-world “risk-treatment-paradox”: highest-risk non-ST-elevation heart-attack patients often do not receive guideline-recommended early invasive care
Implantable cardioverter defibrillators did not improve mortality in selected heart-attack patients with abnormal heart rhythm markers - EurekAlert!
